Kollins John A - Insider Non-Derivative Transactions at Satsuma Pharmaceuticals, Inc. (STSA) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Jun 6, 2023, Kollins John A's relationship to Satsuma Pharmaceuticals, Inc. (STSA) is Director,Officer (President and CEO), and currently has 0 shares of Common Stock, $0.0001 par value.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other STSA insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Kollins John A - Insider Non-Derivative Transactions of STSA Common Stock, $0.0001 par value

Kollins John A - Insider Non-Derivative Transactions at STSA

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Jun 7, 2023	U -- (Common Stock, $0.0001 par value)	305911	0.91	0